Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009

Summary

Continued access to treatment for subjects who continue benefit from therapy with gedatolisib in combination with palbociclib, and fulvestrant or letrozole.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications